West Pharmaceutical Services Inc (WST)
379.47
+0.66
(+0.17%)
USD |
NYSE |
Apr 16, 16:00
379.47
0.00 (0.00%)
After-Hours: 19:43
West Pharmaceutical Services Net Income (Quarterly): 137.00M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 137.00M |
| September 30, 2023 | 161.30M |
| June 30, 2023 | 155.10M |
| March 31, 2023 | 140.00M |
| December 31, 2022 | 103.00M |
| September 30, 2022 | 120.60M |
| June 30, 2022 | 188.50M |
| March 31, 2022 | 173.80M |
| December 31, 2021 | 147.70M |
| September 30, 2021 | 175.60M |
| June 30, 2021 | 187.30M |
| March 31, 2021 | 151.20M |
| December 31, 2020 | 98.40M |
| September 30, 2020 | 82.30M |
| June 30, 2020 | 91.20M |
| March 31, 2020 | 74.30M |
| December 31, 2019 | 63.90M |
| September 30, 2019 | 56.30M |
| June 30, 2019 | 66.10M |
| March 31, 2019 | 55.40M |
| December 31, 2018 | 52.00M |
| September 30, 2018 | 55.20M |
| June 30, 2018 | 56.10M |
| March 31, 2018 | 43.60M |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 51.00M |
| June 30, 2017 | 38.80M |
| March 31, 2017 | 60.90M |
| December 31, 2016 | 39.10M |
| September 30, 2016 | 37.60M |
| June 30, 2016 | 44.70M |
| March 31, 2016 | 22.10M |
| December 31, 2015 | 33.40M |
| September 30, 2015 | 1.50M |
| June 30, 2015 | 27.80M |
| March 31, 2015 | 32.90M |
| December 31, 2014 | 31.40M |
| September 30, 2014 | 31.00M |
| June 30, 2014 | 37.60M |
| March 31, 2014 | 27.10M |
| December 31, 2013 | 23.60M |
| September 30, 2013 | 26.80M |
| June 30, 2013 | 30.20M |
| March 31, 2013 | 31.70M |
| December 31, 2012 | 21.10M |
| September 30, 2012 | 14.80M |
| June 30, 2012 | 15.60M |
| March 31, 2012 | 29.20M |
| December 31, 2011 | 18.80M |
| September 30, 2011 | 16.90M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
56.30M
Minimum
Sep 2019
188.50M
Maximum
Jun 2022
124.93M
Average
137.00M
Median
Dec 2023
Net Income (Quarterly) Benchmarks
| Becton Dickinson & Co | 281.00M |
| Abbott Laboratories | 1.594B |
| Masimo Corp | 33.90M |
| Merit Medical Systems Inc | 27.63M |
| Insulet Corp | 103.30M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 732.00M |
| Total Expenses (Quarterly) | 562.20M |
| EPS Diluted (Quarterly) | 1.83 |
| Enterprise Value | 27.08B |
| Gross Profit Margin (Quarterly) | 38.01% |
| Profit Margin (Quarterly) | 18.72% |
| Earnings Yield | 2.08% |
| Operating Earnings Yield | 2.48% |
| Normalized Earnings Yield | 2.167 |